Want to join the conversation?
$STT 2Q15 Q&A: Serrao from Credit Suisse asked about duration of portfolio. Mike replied yes, we did sell in particular some floating rate ABS securities in 2Q15 and as a result what left in the portfolio does in fact have a longer average duration. Overall duration of the asset-side of our balance sheet did not change materially QoverQ.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?